Skip to main content

Table 6 Determinants of above-median annual total healthcare cost and its components in SSc-DU in multivariable logistic regression

From: Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden

 

OR (95%CI)

p value

Determinants of annual total healthcare cost

 Female

1.21 (0.7–2.1)

0.48

 Age at SSc onset*, years

1.03 (1.0–1.1)

< 0.001

 Caucasian ethnicity

0.55 (0.2–1.6)

0.27

 Diffuse subtype

0.71 (0.4–1.2)

0.19

 ILD

1.38 (0.9–2.2)

0.16

 PAH#

1.78 (0.9–3.2)

0.05

 PDE-5-inhibitor

1.0 (0.6–1.8)

0.99

Iloprost

1.77 (1.1–2.8)

0.02

Determinants of hospital cost

 Female

1.20 (0.7–2.1)

0.49

 Caucasian ethnicity

0.83 (0.3–2.3)

0.72

 Age at SSc onset*, years

1.03 (1.0–1.1)

0.001

 Diffuse subtype

0.97 (0.6–1.6)

0.91

 PAH#

1.32 (0.7–2.3)

0.35

 ILD

1.27 (0.8–1.9)

0.29

 Iloprost

1.59 (1.0–2.5)

0.04

 PDE5 inhibitor

1.13 (0.6–1.9)

0.68

Determinants of ED cost

 Female

1.29 (0.7–2.3)

0.39

 Caucasian ethnicity

0.96 (0.3–2.8)

0.94

 Age at SSc onset*, years

1.02 (0.9–1.0)

0.06

 Diffuse subtype

0.79 (0.5–1.3)

0.37

 PAH#

2.89 (1.4–5.9)

0.004

 ILD

1.29 (0.8–2.1)

0.33

Determinants of MBS cost

 Female

1.79 (1.0–3.2)

0.05

 Age at SSc onset*, years

1.02 (1.0–1.1)

0.001

 Caucasian ethnicity

0.82 (0.3–2.5)

0.001

 Diffuse subtype

0.68 (0.4–1.1)

0.10

 PAH#

2.41 (1.3–4.5)

0.001

DU severity**

 Mild

Baseline

 

 Moderate

1.05 (0.6–1.9)

0.88

 Severe

0.71 (0.3–1.6)

0.39

CVA

3.35 (1.1–10.4)

0.04

Diabetes mellitus

1.51 (0.6–3.8)

0.39

  1. Abbreviations: DU digital ulceration, PAH pulmonary arterial hypertension, ILD interstitial lung disease, CVA cerebrovascular accident, CCB calcium channel blockers, ERAs endothelial receptor antagonists, PDE5 phosphodiesterase-5 inhibitors
  2. *SSc onset defined as the first symptom of SSc (Raynaud phenomenon or other) *disease duration defined as from first non-Raynaud’s disease manifestation
  3. **DU severity was calculated based on the physician reported highest number of new DUs on examination at clinical review (mild 1–5 new DU, moderate 6–10, and severe > 10 new DU)
  4. #PAH diagnosed on right heart catheterization (RHC) according to international criteria [11]